We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
214 hedge funds and large institutions have $4.28B invested in Denali Therapeutics in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 81 increasing their positions, 65 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
139% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $5.19M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
25% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 65
19% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 31
3.2% more ownership
Funds ownership: 66.54% → 69.74% (+3.2%)
2% more funds holding
Funds holding: 210 → 214 (+4)
32% less capital invested
Capital invested by funds: $6.31B → $4.28B (-$2.03B)
Holders
214
Holders Change
+4
Holders Change %
+1.9%
% of All Funds
3.75%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
37
Increased
81
Reduced
65
Closed
31
Calls
$12.4M
Puts
$5.19M
Net Calls
+$7.21M
Net Calls Change
-$15.1M
Top Buyers
| 1 |
PCM
Pathway Capital Management
Irvine,
California
|
+$57.1M |
| 2 |
Temasek Holdings
Singapore
|
+$54.1M |
| 3 |
BlackRock
New York
|
+$29.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$26.9M |
Top Sellers
| 1 |
EC
Euclidean Capital
New York
|
-$25.4M |
| 2 |
CM
Crestline Management
Fort Worth,
Texas
|
-$24.3M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$20.4M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$18.9M |
| 5 |
Jennison Associates
New York
|
-$8.23M |
